Crossmark

The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor

Crossref DOI link: https://doi.org/10.1186/s12933-021-01285-8

Published Online: 2021-04-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chan, Yi-Hsin

Chen, Shao-Wei

Chao, Tze-Fan

Kao, Yi-Wei

Huang, Chien-Ying

Chu, Pao-Hsien
License Information

Text and Data Mining valid from 2021-04-30

Version of Record valid from 2021-04-30
More Information

Article History

Received: 10 March 2021

Accepted: 20 April 2021

First Online: 30 April 2021

Declarations

:

: The study protocol complies with the Declaration of Helsinki and was approved by the Institutional Review Board of the Chang Gung Medical Foundation.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below